Health Care & Life Sciences » Biotechnology | XOMA Corp.

XOMA Corp.

XOMA Corp.
Stock Exchange NASDAQ Stock Market
EPS
 $0.93
Market Cap
 $131.91 M
Shares Outstanding
 8.72 M
Public Float
 7.76 M

Profile

Address
2200 Powell Street
Emeryville California 94608
United States
Employees -
Website http://www.xoma.com
Updated 07/08/2019
XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J.

Financials

View All
Created with Highcharts 5.0.14XOMA Corp.Net Income. Fiscal year is January-December. All values USD Thousands.124 058124 05838 30138 30120 60620 60653 53053 53011 31711 31713 34313 343201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14XOMA Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.35 45135 45118 86618 86655 44755 4475 5645 56452 69052 6905 2995 299201320142015201620172018010k20k30k40k50k60k

James R. Neal
Chief Executive Officer & Director
W. Denman van Ness
Chairman
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.